We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

133 hedge funds and large institutions have $719M invested in Travere Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 60 increasing their positions, 39 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

134% more call options, than puts

Call options by funds: $76.4M | Put options by funds: $32.6M

54% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 39

47% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 17

6% more funds holding

Funds holding: 126 → 133 (+7)

25% less funds holding in top 10

Funds holding in top 10: 8 → 6 (-2)

34% less capital invested

Capital invested by funds: $1.09B → $719M (-$373M)

Holders
133
Holders Change
+7
Holders Change %
+5.56%
% of All Funds
3.71%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.17%
New
25
Increased
60
Reduced
39
Closed
17
Calls
$76.4M
Puts
$32.6M
Net Calls
+$43.8M
Net Calls Change
+$5.07M

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$19.7M
2
SAM
Senzar Asset Management
New York
+$15.2M
3
Goldman Sachs
Goldman Sachs
New York
+$14.4M
4
Invesco
Invesco
Georgia
+$14.4M
5
BC
Broadfin Capital
New York
+$13.2M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$20.4M
2
Millennium Management
Millennium Management
New York
-$10.9M
3
LCM
Laurion Capital Management
New York
-$7.55M
4
WSA
Wall Street Associates
California
-$7.02M
5
PI
Putnam Investments
Massachusetts
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$6.97M +$733K +24,744 +8%
WSA
27
Wall Street Associates
California
$6.36M -$7.02M -237,100 -43%
BNP Paribas Asset Management
28
BNP Paribas Asset Management
France
$6.18M +$1.88M +63,620 +26%
QF
29
QVT Financial
New York
$6.01M +$8.78M +296,570 New
Macquarie Group
30
Macquarie Group
Australia
$5.99M +$2.52M +85,040 +40%
PWAM
31
Park West Asset Management
California
$5.87M -$1.16M -39,075 -12%
Two Sigma Investments
32
Two Sigma Investments
New York
$5.81M +$8.05M +271,614 +1,768%
Morgan Stanley
33
Morgan Stanley
New York
$5.48M +$1.43M +48,411 +22%
EAM
34
Eventide Asset Management
Massachusetts
$4.88M +$2.24M +75,500 +46%
TI
35
Turner Investments
Pennsylvania
$4.82M +$2.81M +94,800 +66%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$4.55M +$99.9K +3,373 +2%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$4.15M +$5.62M +189,607 +2,709%
WRF
38
Waddell & Reed Financial
Kansas
$3.98M +$5.81M +196,300 New
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$3.93M -$1.46M -49,300 -20%
SIM
40
Spark Investment Management
New York
$3.91M +$3.08M +103,900 +116%
CM
41
Castleark Management
Illinois
$3.61M -$1.94M -65,616 -27%
EAM
42
EverPoint Asset Management
Connecticut
$3.55M +$1.78M +60,000 +52%
TA
43
Teachers Advisors
New York
$3.49M +$22.1K +745 +0.4%
SFM
44
Sphera Funds Management
Israel
$3.04M +$4.44M +150,000 New
TI
45
Telemetry Investments
New York
$3M -$74.1K -2,500 -2%
Connor, Clark & Lunn Investment Management (CC&L)
46
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$2.94M -$243K -8,200 -5%
NCGI
47
Next Century Growth Investors
Minnesota
$2.89M -$827K -27,922 -16%
Loomis, Sayles & Company
48
Loomis, Sayles & Company
Massachusetts
$2.68M +$3.92M +132,207 New
TCIM
49
TIAA CREF Investment Management
New York
$2.67M -$163K -5,509 -4%
Citadel Advisors
50
Citadel Advisors
Florida
$2.66M +$526K +17,758 +16%
1
2
3 4 5

TVTX Hedge Fund Activity: Q3 2015 in Review

133 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q3 2015, worth a combined $719M — down 34% from $1.09B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new TVTX positions and 17 closed out — a net gain of 8 holders — while 60 added to existing stakes and 39 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $19.7M. The largest seller was Jennison Associates, cutting an estimated $20.4M.

  • 133 institutional investors held Travere Therapeutics (TVTX) as of Q3 2015, up from 126 in Q2 2015.
  • Funds reported $719M of Travere Therapeutics stock for Q3 2015, down 34% quarter-over-quarter.
  • 25 funds opened new Travere Therapeutics positions in Q3 2015 and 17 closed out, a net change of +8 holders.
  • The largest Travere Therapeutics buyer in Q3 2015 was EcoR1 Capital, an estimated $19.7M added.
  • The largest Travere Therapeutics seller in Q3 2015 was Jennison Associates, an estimated $20.4M sold.

Based on aggregated 13F filings for Q3 2015.